Literature DB >> 8215542

Galactosaemia: results of the British Paediatric Surveillance Unit Study, 1988-90.

M M Honeyman1, A Green, J B Holton, J V Leonard.   

Abstract

Ascertainment of cases of classical galactosaemia over a three year period in the UK and the Republic of Ireland, through the British Paediatric Surveillance Unit, identified 58 proved cases and two in whom the diagnosis was strongly suspected. One patient died at 4 days, and severe morbidity was no more frequent in babies diagnosed clinically because of their symptoms compared with those who were screened for galactosaemia. Treatment of four babies in the non-screened group was delayed until after 5 weeks of age, but it is concluded that all cases of galactosaemia could be diagnosed in an acceptable time without screening, providing clinical vigilance is maintained.

Entities:  

Mesh:

Year:  1993        PMID: 8215542      PMCID: PMC1029515          DOI: 10.1136/adc.69.3.339

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  Long-term prognosis in galactosaemia: results of a survey of 350 cases.

Authors:  D D Waggoner; N R Buist; G N Donnell
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  A simple spot screening test for galactosemia.

Authors:  E Beutler; M C Baluda
Journal:  J Lab Clin Med       Date:  1966-07

3.  Diagnosis of classical galactosaemia.

Authors:  A M Monk; A J Mitchell; D W Milligan; J B Holton
Journal:  Arch Dis Child       Date:  1977-12       Impact factor: 3.791

4.  Neonatal screening and an intensive management programme for galactosaemia: early evidence of benefits.

Authors:  A Hayes; F G Bowling; D Fraser; H L Krimmer; A Marrinan; A E Clague
Journal:  Med J Aust       Date:  1988-07-04       Impact factor: 7.738

  4 in total
  15 in total

1.  A controversial expert witness.

Authors: 
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

2.  Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group.

Authors:  J H Walter; J E Collins; J V Leonard
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

3.  The neuropsychological profile of galactosaemia.

Authors:  Claire M Doyle; Shelley Channon; Danuta Orlowska; Philip J Lee
Journal:  J Inherit Metab Dis       Date:  2010-07-06       Impact factor: 4.982

Review 4.  Newborn mass screening for galactosemia.

Authors:  S Schweitzer
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

5.  Incidence and features of galactosaemia in Saudi Arabs.

Authors:  H Moammar; R Ratard; G Cheriyan; P Mathew
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 6.  Newborn screening for galactosaemia.

Authors:  Rohollah Lak; Bahareh Yazdizadeh; Majid Davari; Mojtaba Nouhi; Roya Kelishadi
Journal:  Cochrane Database Syst Rev       Date:  2017-12-23

Review 7.  Appropriateness of newborn screening for classic galactosaemia: a systematic review.

Authors:  L Varela-Lema; L Paz-Valinas; G Atienza-Merino; R Zubizarreta-Alberdi; R Vizoso Villares; M López-García
Journal:  J Inherit Metab Dis       Date:  2016-04-26       Impact factor: 4.982

Review 8.  Classical galactosaemia revisited.

Authors:  Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

9.  The relationship of genotype to cognitive outcome in galactosaemia.

Authors:  J P Shield; E J Wadsworth; A MacDonald; A Stephenson; L Tyfield; J B Holton; N Marlow
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

10.  Diversity of approaches to classic galactosemia around the world: a comparison of diagnosis, intervention, and outcomes.

Authors:  Patricia P Jumbo-Lucioni; Kathryn Garber; John Kiel; Ivo Baric; Gerard T Berry; Annet Bosch; Alberto Burlina; Ana Chiesa; Maria Luz Couce Pico; Sylvia C Estrada; Howard Henderson; Nancy Leslie; Nicola Longo; Andrew A M Morris; Carlett Ramirez-Farias; Susanne Schweitzer-Krantz; Susanne Scheweitzer-Krantz; Catherine Lynn T Silao; Marcela Vela-Amieva; Susan Waisbren; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2012-03-27       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.